Although VIZZ is, so far, the first and only FDA-approved aceclidine eye drop, it’s one of three prescription eye drops ...

The Food and Drug Administration has issued warning letters to several companies producing whipped formulas of sunscreen.

The U.S. Food and Drug Administration is suspending the biologics license for the live-attenuated chikungunya vaccine, Ixchiq ...

The recalls have been classified as Class II, where the probability of serious adverse health consequences is remote.

With the FDA’s go-ahead, Coya plans to launch a multicenter phase 2 trial of COYA 302 in patients with ALS, CEO Arun ...

Drugmaker Novo Nordisk received accelerated approval for the drug’s use in people with moderate to advanced liver scarring, ...

As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its ...

Hey, good morning. Today, we see CBER suspend the license for a chikungunya vaccine, look at a push to recall a safety and ...

There have been 4 new reports of serious adverse events related to Ixchiq based on updated Vaccine Adverse Event Reporting System data.

FDA delays Axogen's Avance Nerve Graft BLA review to December 5, after new data submission, while the company raises its full ...

On Tuesday, the Food and Drug Administration (FDA) warned consumers about potential contamination of a well-known brand of ...

A. The Food and Drug Administration has approved montelukast to treat asthma, exercise-induced bronchoconstriction (trouble ...